Study of Adefovir Dipivoxil for Korean Patients With Chronic Hepatitis B(CHB) Who Have Completed ADF 103814
Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
This is an open label, single-arm, multi-centre extension study for Korean patients with
chronic hepatitis B and compensated liver disease who have completed one-year adefovir
dipivoxil treatment in ADF103814. The objective is to assess clinical efficacy and safety of
long term (up to 3 years) adefovir dipivoxil 10mg therapy.